KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) EPS (Basic) (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed EPS (Basic) for 17 consecutive years, with $2.12 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 49.3% to $2.12 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.13 through Dec 2025, up 90.58% year-over-year, with the annual reading at $11.13 for FY2025, 90.58% up from the prior year.
  • EPS (Basic) hit $2.12 in Q4 2025 for Johnson & Johnson, down from $2.14 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $4.57 in Q1 2025 to a low of -$0.19 in Q2 2023.
  • Historically, EPS (Basic) has averaged $1.77 across 5 years, with a median of $1.72 in 2022.
  • Biggest five-year swings in EPS (Basic): tumbled 110.92% in 2023 and later soared 810.53% in 2024.
  • Year by year, EPS (Basic) stood at $1.39 in 2021, then grew by 17.99% to $1.64 in 2022, then rose by 4.27% to $1.71 in 2023, then fell by 16.96% to $1.42 in 2024, then soared by 49.3% to $2.12 in 2025.
  • Business Quant data shows EPS (Basic) for JNJ at $2.12 in Q4 2025, $2.14 in Q3 2025, and $2.3 in Q2 2025.